TY - JOUR
T1 - Community cholesterol screening
T2 - Medical follow-up in subjects identified with high plasma cholesterol levels
AU - Morris, Cynthia D.
AU - Menashe, Victor D.
AU - Anderson, Peter H.
AU - Malinow, M. Rene
AU - Illingworth, D. Roger
PY - 1990/9
Y1 - 1990/9
N2 - Population screening for plasma cholesterol is an effective method of detecting hypercholesterolemia; however, follow-up and treatment are essential components of such a progrma. After a city-wide screening in 1987 of more than 19,872 persons, using a mailed survey with a response rate of 48%, we evaluated subsequent actions of 3,078 individuals with high plasma cholesterol levels. Slightly more than half the population was aware of high blood cholesterol levels prior to the time of screening and apparently used the program for follow-up. Overall, after the screening, 65% consulted a physician within 5 months of screening and blood cholesterol levels were remeasured in 80% of the sample. Procastination and expense were cited as the primary reasons for failing to consult a physician. If screening is to be effectively utilized as a means of reducing the prevalence of high plasma cholesterol levels, diligent follow-up must be made of all individuals identified to be at increased risk on the basis of their initial values.
AB - Population screening for plasma cholesterol is an effective method of detecting hypercholesterolemia; however, follow-up and treatment are essential components of such a progrma. After a city-wide screening in 1987 of more than 19,872 persons, using a mailed survey with a response rate of 48%, we evaluated subsequent actions of 3,078 individuals with high plasma cholesterol levels. Slightly more than half the population was aware of high blood cholesterol levels prior to the time of screening and apparently used the program for follow-up. Overall, after the screening, 65% consulted a physician within 5 months of screening and blood cholesterol levels were remeasured in 80% of the sample. Procastination and expense were cited as the primary reasons for failing to consult a physician. If screening is to be effectively utilized as a means of reducing the prevalence of high plasma cholesterol levels, diligent follow-up must be made of all individuals identified to be at increased risk on the basis of their initial values.
UR - http://www.scopus.com/inward/record.url?scp=0025182750&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025182750&partnerID=8YFLogxK
U2 - 10.1016/0091-7435(90)90048-O
DO - 10.1016/0091-7435(90)90048-O
M3 - Article
C2 - 2235918
AN - SCOPUS:0025182750
SN - 0091-7435
VL - 19
SP - 493
EP - 501
JO - Preventive Medicine
JF - Preventive Medicine
IS - 5
ER -